Translational Psychiatry Impact Factor, Quartile, Indexing, Ranking

Translational Psychiatry (TP) is a scholarly journal dedicated to publishing research in the field of Neuroscience, and Published by Nature Publishing. The Print-ISSN of Translational Psychiatry is 2158-3188 and its abbreviation is Transl Psychiatry.

The Publicaiton fees (APC) is £3190.00, $4790.00, €3590.00.

Psychiatry has been held back by our limited translational pipeline. Nobel laureate Julius Axelrod's discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of most commonly prescribed types of antidepressants treatment. Likewise, dopamine receptor antagonists are widely used to treat schizophrenia. Pierre Deniker and Jean Delay conducted a clinical trial at the Sainte-Anne Hospital Center in Paris in which they treated 38 psychotic patients with daily injections of chlorpromazine, a dopamine receptor antagonist, without the use of other sedating agents. The response was dramatic; treatment with chlorpromazine went beyond simple sedation with patients showing improvements in thinking and emotional behavior. That was first reported in 1952.

• Journal Website
• PubMed
• Scopus
• SCImago